Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc. engages in the provision of medical services. The firm offers specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, and dental services. Its multi-disciplinary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its clinics, affiliate clinics, retirement homes, and long-term facilities. The firm operates through the following business segments: healthcare services, and product manufacturing and development. The company was founded by Michael H. Rouse on November 27, 2000 and is headquartered in Bellevue, WA.

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Novo Integrated Sciences, Inc. engages in the provision of medical services. The firm offers specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, and dental services. Its multi-disciplinary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its clinics, affiliate clinics, retirement homes, and long-term facilities. The firm operates through the Healthcare Services and Product Sales segments. The company was founded by Michael H. Rouse on November 27, 2000 and is headquartered in Bellevue, WA.

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #NovoConnect--Novo Integrated Sciences Signs LOIs to Acquire Seven Pharmacies in the United States

Novo Integrated Sciences Signs LOIs to Acquire Seven Pharmacies in the United States

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #biotech--Co-Founded by Mark Wahlberg and industry executive, Tom Dowd, PI Nutrition completes a licensing agreement with Aceniza, Inc. (an NVOS subsidiary).

Novo Integrated Sciences' Subsidiary, Acenzia, Signs Exclusive Licensing Agreement with Performance Inspired Nutrition to Manufacture and Distribute in the Middle East

The ‘new' reality of the COVID-19 pandemic, ongoing advancements in medical technology, inter-connectivity, and blockchain technology, are all key drivers in the global healthcare system making critical early adoptions of many overdue improvements. Patients are confronted, now more than ever, with a complicated, overlapping landscape of multiple access points and applications where care providers, insurers and patients globally struggle to quickly and efficiently provide patient care.

Novo Integrated Sciences Launches New Patient Portal App Giving Patients More Control Over Their Healthcare

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Third Quarter 2021 Financial Results

Novo Integrated Sciences Announces Third Quarter 2021 Financial Results

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Appoints Dr. Indrajit (Indra) Sinha Ph.D. as Chief Science Officer

Novo Integrated Sciences Appoints Dr. Indrajit (Indra) Sinha Ph.D. as Chief Science Officer

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences and Novo Healthnet Limited Complete Acquisition of Acenzia

Novo Integrated Sciences and Novo Healthnet Limited Complete Acquisition of Acenzia

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire Acenzia Inc.

Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire Acenzia Inc.

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Completes Acquisition of PRO-DIP, LLC

Novo Integrated Sciences Completes Acquisition of PRO-DIP, LLC

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire PRO-DIP, LLC

Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire PRO-DIP, LLC

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Formation of Medical Advisory Board

Novo Integrated Sciences Announces Formation of Medical Advisory Board

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Closing of $8 Million Registered Direct Offering

Novo Integrated Sciences Announces Closing of $8 Million Registered Direct Offering

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Second Quarter 2021 Financial Results

Novo Integrated Sciences Announces Second Quarter 2021 Financial Results

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Pricing of $8.0 Million Registered Direct Offering

Novo Integrated Sciences Announces Pricing of $8.0 Million Registered Direct Offering

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Preliminary Revenue and Financial Results of Second Quarter Fiscal Year ‘21

Novo Integrated Sciences Announces Preliminary Revenue and Financial Results of Second Quarter Fiscal Year ‘21

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference, March 17-19, 2021

Novo Integrated Sciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference, March 17-19, 2021

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences (NASDAQ:NVOS) Announces New Executive Hires for Novo Healthnet Limited

Novo Integrated Sciences Announces New Executive Hires for Novo Healthnet Limited

Novo Integrated Sciences (NVOS) stock is taking off on Wednesday following an uplist to the Nasdaq Exchange and heavy trading of its shares. The post NVOS Stock Alert: 5 Things to Know About Novo Integrated Sciences as It Blasts Higher appeared first on InvestorPlace.

NVOS Stock Alert: 5 Things to Know About Novo Integrated Sciences as It Blasts Higher

Shares of Novo Integrated Sciences Inc. rallied 83% in volatile morning trading Wednesday, but have pulled back sharply from earlier highs, on the primary care services and products company's second day as a Nasdaq-listed company. The stock, currently around its intraday lows, had traded up as much as 275.4% at its intraday high of $14.98.

Novo Integrated Sciences stock surges, but pulls back sharply in volatile trading

Novo Integrated Sciences shares soared early Wednesday after the healthcare services provider's move onto the Nasdaq Capital Market. The shares had been trading on the over-the-counter market before the move to Nasdaq. The stock jumped as much as 878% to $39.03 during premarket trade Wednesday, overcoming a 0.3% slip on Tuesday after moving onto the exchange. The gain ahead of Wednesday's opening bell was pared to 384% at around $19.33.

Novo Integrated Sciences soars 878% as it moves from over-the-counter trading to Nasdaq Capital Market (NVOS)

The stock price of Novo Integrated Sciences, Inc. (NASDAQ: NVOS) increased by over 500% pre-market. This is why it happened.

NVOS Stock Price Increases Over 500% Pre-Market: Why It Happened

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Approved for listing on The Nasdaq Capital Market, effective 2/23/21.

Novo Integrated Sciences Announces Uplist to The Nasdaq Capital Market

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--James Asher appointed as new President of Novo Healthnet Limited, wholly-owned Canadian subsidiary of Novo Integrated Sciences.

Novo Integrated Sciences Announces New President of Novo Healthnet Limited

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences effects, on 2/1/21, a 1:10 reverse stock split of its common stock in connection with its application for uplist to Nasdaq.

Novo Integrated Sciences Effects Reverse Stock Split in Connection with Nasdaq Capital Market Listing Application

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Three New Independent Directors Appointed to its Board of Directors and Formation of an Audit Committee.

Novo Integrated Sciences Announces Three New Independent Directors Appointed to its Board of Directors and Formation of an Audit Committee

Bellevue, Washington, November 18, 2020 – OTC PR WIRE – Novo Integrated Sciences, Inc. (OTC US: NVOS), a provider of multi-dimensional primary healthcare services and products in Canada and the U.S. (the “Company”), announces it has engaged Investor Acquisition Advisors to enhance the investor community's market awareness of Novo Integrated Sciences through Investor Acquisition Advisors' expertise and its proprietary investor acquisition equity research and digital marketing platform.

News for Novo Integrated Sciences, Inc. Stock (NVOS)